Irvine, CA, United States of America

Neil Parikh

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Xellia Pharmaceuticals Aps. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Parikh. Retrieved from https://idiyas.com/inventor/neil-parikh-22mmgvuv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Parikh: Innovator in Pharmaceutical Composition

Introduction

Neil Parikh is a notable inventor based in Irvine, California. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on caspofungin compositions.

Latest Patents

Neil Parikh holds a patent for a composition comprising caspofungin or a pharmaceutical acceptable salt thereof, along with succinate or lactate as a buffering agent. This invention is crucial for enhancing the efficacy of caspofungin in medical applications.

Career Highlights

Neil Parikh is currently associated with Xellia Pharmaceuticals Aps, where he continues to work on advancing pharmaceutical formulations. His expertise in this area has positioned him as a valuable asset to the company.

Collaborations

Some of his coworkers include Swapnil P Shirode and Piyush Patel, who collaborate with him on various projects within the pharmaceutical sector.

Conclusion

Neil Parikh's contributions to pharmaceutical innovations, particularly through his patent on caspofungin composition, highlight his role as a key inventor in the industry. His work continues to impact the field positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…